147 related articles for article (PubMed ID: 2981223)
1. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria.
Wang JY; Baltimore D
J Biol Chem; 1985 Jan; 260(1):64-71. PubMed ID: 2981223
[TBL] [Abstract][Full Text] [Related]
2. An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase.
Lydon NB; Adams B; Poschet JF; Gutzwiller A; Matter A
Oncogene Res; 1990; 5(3):161-73. PubMed ID: 2157186
[TBL] [Abstract][Full Text] [Related]
3. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.
Prywes R; Foulkes JG; Baltimore D
J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108
[TBL] [Abstract][Full Text] [Related]
4. Isolation and analysis of an Abelson murine leukemia virus-encoded tyrosine-specific kinase produced in Escherichia coli.
Ferguson B; Pritchard ML; Feild J; Rieman D; Greig RG; Poste G; Rosenberg M
J Biol Chem; 1985 Mar; 260(6):3652-7. PubMed ID: 2982873
[TBL] [Abstract][Full Text] [Related]
5. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
Watanabe SM; Rosenberg NE; Witte ON
J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
[TBL] [Abstract][Full Text] [Related]
6. Structure and function of the Abelson murine leukemia virus transforming gene.
Wang JY; Prywes R; Baltimore D
Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
[TBL] [Abstract][Full Text] [Related]
7. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
Rees-Jones RW; Goff SP
J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
[TBL] [Abstract][Full Text] [Related]
8. A truncated v-abl-derived tyrosine-specific tyrosine kinase expressed in Escherichia coli.
Pritchard ML; Rieman D; Feild J; Kruse C; Rosenberg M; Poste G; Greig RG; Ferguson BQ
Biochem J; 1989 Jan; 257(2):321-9. PubMed ID: 2539083
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
Reddy EP; Smith MJ; Srinivasan A
Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.
Foulkes JG; Chow M; Gorka C; Frackelton AR; Baltimore D
J Biol Chem; 1985 Jul; 260(13):8070-7. PubMed ID: 2989275
[TBL] [Abstract][Full Text] [Related]
11. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
Engelman A; Rosenberg N
J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
[TBL] [Abstract][Full Text] [Related]
12. Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.
Davis RL; Konopka JB; Witte ON
Mol Cell Biol; 1985 Jan; 5(1):204-13. PubMed ID: 4039028
[TBL] [Abstract][Full Text] [Related]
13. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity.
Kloetzer W; Kurzrock R; Smith L; Talpaz M; Spiller M; Gutterman J; Arlinghaus R
Virology; 1985 Jan; 140(2):230-8. PubMed ID: 2982232
[TBL] [Abstract][Full Text] [Related]
14. Expression of an Abelson murine leukemia virus-encoded protein in Escherichia coli causes extensive phosphorylation of tyrosine residues.
Wang JY; Queen C; Baltimore D
J Biol Chem; 1982 Nov; 257(22):13181-4. PubMed ID: 6292177
[TBL] [Abstract][Full Text] [Related]
15. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
Shore SK; Bogart SL; Reddy EP
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
[TBL] [Abstract][Full Text] [Related]
16. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
[TBL] [Abstract][Full Text] [Related]
17. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
Engelman A; Rosenberg N
Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules.
Schiff-Maker L; Burns MC; Konopka JB; Clark S; Witte ON; Rosenberg N
J Virol; 1986 Mar; 57(3):1182-6. PubMed ID: 3005619
[TBL] [Abstract][Full Text] [Related]
19. Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.
Kipreos ET; Lee GJ; Wang JY
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1345-9. PubMed ID: 2434953
[TBL] [Abstract][Full Text] [Related]
20. Abelson transformed fibroblasts lacking the EGF receptor are not tumourigenic in nude mice.
Gebhardt A; Bell JC; Foulkes JG
EMBO J; 1986 Sep; 5(9):2191-5. PubMed ID: 3023060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
